Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

  136,880,248      
Direct Value   $2,518,008,348    

Indirect Value

  $7,546,182,718      
Total Shares   186,710,189      
Total Value   $10,064,191,065      


Neurocrine Biosciences Inc
 $704,088,488 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $47,110,150 Ligand Pharmaceuticals Inc
 $1,306,436,094 Curis Inc
 $3,390,252 Repligen Corp
 $455,929,095 Gyre Therapeutics
 $1,054,262 Neurocrine Biosciences Inc
 $704,088,488 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $47,110,150 Ligand Pharmaceuticals Inc
 $1,306,436,094 Curis Inc
 $3,390,252 Repligen Corp
 $455,929,095 Gyre Therapeutics
 $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    19   
    2    

     Stock price went up :

    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2008-10-06 3 IO $0.00 $0 D/D 0 4,107,899 -
CAPS Capstone Therapeutics Cor... 10% Owner   –       –       •   2008-10-07 3 IO $0.00 $0 D/D 0 3,950,288 -
ADLR Adolor Corp 10% Owner   –       –       •   2008-10-10 3 IO $0.00 $0 D/D 0 4,428,032 -
DVAX Dynavax Technologies Corp 10% Owner   –       –       •   2008-10-23 3 IO $0.00 $0 D/D 0 8,132,657 -
CRIS Curis Inc 10% Owner   –       –       •   2009-02-03 3 IO $0.00 $0 D/D 0 8,921,716 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-21 4 B $0.45 $5,400 I/I 12,000 8,315,999 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-24 4 B $0.45 $37,395 I/I 83,100 8,399,099 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-25 4 B $0.47 $5,754 I/I 12,300 8,411,399 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-26 4 B $0.49 $3,260 I/I 6,600 8,417,999 1.42 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-03 4 B $0.54 $7,216 I/I 13,400 8,467,999 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-01 4 B $0.55 $14,740 I/I 26,800 8,444,799 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-02 4 B $0.55 $5,356 I/I 9,800 8,454,599 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-04 4 B $0.55 $5,665 I/I 10,300 8,478,299 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-05 4 B $0.57 $872,425 I/I 1,530,572 10,008,871 1.5 -
CAPS Capstone Therapeutics Cor... Indirect Beneficial Owner   –       –       •   2008-10-10 4 B $0.58 $136,753 I/I 237,500 4,187,788 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-07 4 B $0.58 $63,264 I/I 109,700 8,129,099 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $0.58 $8,120 I/I 14,000 8,143,099 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-06 4 B $0.59 $6,584 I/I 11,200 8,019,399 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-10 4 B $0.60 $34,893 I/I 58,300 5,059,299 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-05 4 B $0.60 $108,186 I/I 180,400 8,008,199 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $0.60 $83,224 I/I 139,100 8,282,199 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $0.60 $2,159 I/I 3,600 8,285,799 1.42 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-13 4 B $0.60 $5,400 I/I 9,000 8,294,799 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-14 4 B $0.60 $5,486 I/I 9,200 8,303,999 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-08 4 B $0.62 $63,829 I/I 103,100 5,000,999 1.5 -

  195  Records found
  1  2   3   4   5   6   7   8      
  Page 1 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed